Bergenbio ASA Financials
| BGBIO Stock | NOK 1.64 0.03 1.80% |
Bergenbio |
Understanding current and past Bergenbio ASA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bergenbio ASA's financial statements are interrelated, with each one affecting the others. For example, an increase in Bergenbio ASA's assets may result in an increase in income on the income statement.
Bergenbio ASA Stock Summary
Bergenbio ASA competes with PCI Biotech, Photocure, and XXL ASA. BerGenBio ASA, a clinical-stage biopharmaceutical company, develops medicines to treat immune evasive, drug resistant, and metastatic cancers. The company was founded in 2007 and is headquartered in Bergen, Norway. BerGenBio ASA is traded on Oslo Stock Exchange in Norway.| Instrument | Norway Stock View All |
| Exchange | Oslo Stock Exchange |
| ISIN | NO0010650013 |
| Business Address | Jonas Lies vei |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.bergenbio.com |
| Phone | 47 55 96 11 59 |
| Currency | NOK - Kroner |
You should never invest in Bergenbio ASA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bergenbio Stock, because this is throwing your money away. Analyzing the key information contained in Bergenbio ASA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Bergenbio ASA Key Financial Ratios
Bergenbio ASA's financial ratios allow both analysts and investors to convert raw data from Bergenbio ASA's financial statements into concise, actionable information that can be used to evaluate the performance of Bergenbio ASA over time and compare it to other companies across industries.| Return On Equity | -0.96 | |||
| Return On Asset | -0.49 | |||
| Target Price | 20.25 | |||
| Number Of Employees | 34 | |||
| Beta | 1.63 |
Bergenbio Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bergenbio ASA's current stock value. Our valuation model uses many indicators to compare Bergenbio ASA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bergenbio ASA competition to find correlations between indicators driving Bergenbio ASA's intrinsic value. More Info.Bergenbio ASA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bergenbio ASA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bergenbio ASA's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Bergenbio ASA Systematic Risk
Bergenbio ASA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bergenbio ASA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Bergenbio ASA correlated with the market. If Beta is less than 0 Bergenbio ASA generally moves in the opposite direction as compared to the market. If Bergenbio ASA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bergenbio ASA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bergenbio ASA is generally in the same direction as the market. If Beta > 1 Bergenbio ASA moves generally in the same direction as, but more than the movement of the benchmark.
Bergenbio ASA March 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bergenbio ASA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bergenbio ASA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bergenbio ASA based on widely used predictive technical indicators. In general, we focus on analyzing Bergenbio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bergenbio ASA's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 106.42 | |||
| Value At Risk | (8.73) | |||
| Potential Upside | 13.08 |
Other Information on Investing in Bergenbio Stock
Bergenbio ASA financial ratios help investors to determine whether Bergenbio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bergenbio with respect to the benefits of owning Bergenbio ASA security.